Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
NEUROLOGY	O
Allergies:	O
Diltiazem	O
/	O
Vasotec	O
/	O
Cardizem	O
/	O
Dicloxacillin	O
/	O
Vioxx	O
/	O
Codeine	O
/	O
Shellfish	O
Derived	O
/	O
ranolazine	O
Attending:	O
___	O
Chief	O
Complaint:	O
Transient	O
facial	O
weakness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
The	O
patient	O
is	O
an	O
___	O
year	O
old	O
___	O
woman	O
with	O
a	O
history	O
of	O
afib	O
on	O
Coumadin	O
(INR	O
3.0),	O
CAD,	O
CHF	O
EF	O
40%,	O
prior	O
L	O
MCA	O
stroke	O
___,	O
HTN,	O
CKD	O
baseline	O
Cr	O
2.0-2.5,	O
presenting	O
with	O
shortness	O
of	O
breath	O
and	O
facial	O
droop	O
which	O
is	O
now	O
resolved.	O
The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
yesterday.	O
Last	O
night	O
for	O
dinner	O
she	O
had	O
steak,	O
rice,	O
and	O
peas,	O
and	O
ice	O
cream.	O
This	O
morning	O
when	O
she	O
woke	O
up	O
she	O
was	O
feeling	O
short	O
of	O
breath	O
and	O
generally	O
unwell.	O
Her	O
daughter	O
came	O
and	O
noted	O
a	O
L	O
facial	O
droop,	O
which	O
she	O
had	O
never	O
noted	O
on	O
prior	O
occasions.	O
The	O
patient	O
herself	O
thought	O
she	O
felt	O
that	O
her	O
face	O
was	O
"pulling	O
to	O
the	O
R	O
side."	O
This	O
has	O
improved	O
since	O
this	O
morning	O
per	O
the	O
daughter,	O
and	O
is	O
milder	O
at	O
the	O
time	O
of	O
evaluation	O
in	O
the	O
ED,	O
but	O
her	O
face	O
still	O
looks	O
asymmetric.	O
The	O
ED	O
resident	O
felt	O
at	O
the	O
time	O
of	O
initial	O
evaluation	O
there	O
was	O
a	O
prominent	O
facial	O
droop	O
("2	O
on	O
NIHSS")	O
which	O
was	O
resolving	O
when	O
Neurology	O
saw	O
the	O
patient.	O
She	O
has	O
had	O
several	O
episodes	O
of	O
dizziness	O
which	O
she	O
describes	O
as	O
"wobbly",	O
denies	O
vertigo.	O
She	O
gets	O
these	O
periodically,	O
often	O
after	O
she	O
gets	O
up	O
in	O
the	O
morning,	O
and	O
they	O
are	O
transient.	O
She	O
had	O
an	O
episode	O
of	O
dizziness	O
yesterday	O
while	O
getting	O
into	O
a	O
van	O
to	O
come	O
home	O
from	O
her	O
day	O
program,	O
and	O
another	O
episode	O
this	O
morning	O
getting	O
out	O
of	O
bed.	O
This	O
is	O
not	O
very	O
atypical	O
for	O
her.	O
She	O
endorses	O
baseline	O
R	O
sided	O
weakness	O
after	O
her	O
stroke	O
in	O
___,	O
this	O
is	O
not	O
worse	O
than	O
usual.	O
Past	O
Medical	O
History:	O
#CAD	O
-	O
status	O
post	O
myocardial	O
infarction	O
in	O
___	O
with	O
an	O
left	O
anterior	O
descending	O
stent,	O
status	O
post	O
coronary	O
artery	O
bypass	O
graft;	O
SVG-OM2,	O
SVG-D2,	O
LIMA-LAD.	O
Cardiac	O
cath	O
___	O
showing	O
patent	O
grafts	O
with	O
severe	O
native	O
3vd.	O
P-MIBI	O
in	O
___	O
showing	O
severe	O
fixed	O
defect	O
of	O
anterior	O
wall,	O
mild	O
fixed	O
defect	O
in	O
septum	O
#Systolic	O
CHF:	O
LVEF	O
40%	O
in	O
___,	O
moderate	O
MR,	O
moderate	O
TR	O
#AFib	O
-	O
On	O
Coumadin	O
#Hypertension	O
#Moderate	O
MR	O
#CKD-	O
baseline	O
creatinine	O
___	O
#PAF	O
#CVA	O
in	O
___	O
(post-op	O
CABG).	O
With	O
residual	O
right	O
arm	O
deficits.	O
MRI/MRA	O
___	O
showing	O
old	O
left	O
parietal	O
lobe	O
infarct,	O
decreased	O
flow	O
basilar	O
artery;	O
all	O
unchanged	O
from	O
prior	O
studies	O
#History	O
of	O
gout.	O
#OSA,	O
on	O
bipap	O
#Colonoscopy	O
___	O
of	O
distal	O
sigmoid;	O
path	O
c/w	O
hyperplastic	O
polyp	O
#Bilateral	O
TKR's	O
___	O
#s/p	O
Hysterectomy	O
#s/p	O
cholecystectomy	O
#Lumbar	O
spinal	O
stenosis	O
leading	O
to	O
likely	O
neurogenic	O
claudication	O
symptoms	O
#Stable	O
breast	O
nodule,	O
unchanged	O
Social	O
History:	O
___	O
Family	O
History:	O
Sister	O
with	O
history	O
of	O
CHF.	O
Otherwise,	O
non-contributory.	O
Physical	O
Exam:	O
Exam	O
on	O
dischage:	O
-	O
Mental	O
Status	O
-	O
Awake,	O
alert,	O
oriented	B-Delirium
x	B-Delirium
3.	B-Delirium
Attention	O
to	O
examiner	O
easily	O
attained	O
and	O
maintained.	O
Fluent	O
with	O
full	O
sentences,	O
intact	O
repetition,	O
and	O
intact	O
verbal	O
comprehension.	O
Content	O
of	O
speech	O
demonstrates	O
intact	O
naming	O
(high	O
and	O
low	O
frequency)	O
and	O
no	O
paraphasias.	O
Normal	O
prosody.	O
No	O
dysarthria.	O
No	O
evidence	O
of	O
hemineglect.	O
No	O
left-right	O
agnosia.	O
-	O
Cranial	O
Nerves	O
-	O
I.	O
not	O
tested	O
II.	O
PERRL.	O
Visual	B-Visual_impairment
fields	B-Visual_impairment
were	O
full	B-Visual_impairment
to	O
finger	O
wiggling.	O
III,	O
IV,	O
VI.	O
Smooth	O
and	O
full	O
extraocular	O
movements	O
without	O
diplopia	B-Visual_impairment
or	O
nystagmus.	O
V.	O
facial	O
sensation	O
was	O
intact,	O
muscles	O
of	O
mastication	O
with	O
full	O
strength	O
VII.	O
No	O
facial	O
weakness	O
appreciated	O
VIII.	O
Hearing	B-Hearing_impairment
was	O
intact	B-Hearing_impairment
to	O
finger	O
rub	O
bilaterally.	O
IX,	O
X.	O
Symmetric	O
palate	O
elevation	O
and	O
symmetric	O
tongue	O
protrusion	O
with	O
full	O
movement.	O
XI.	O
SCM	O
and	O
trapezius	O
were	O
of	O
normal	O
strength	O
and	O
volume.	O
-	O
Motor	O
-	O
Muscule	O
bulk	O
and	O
tone	O
were	O
normal.	O
No	O
drift	O
appreciated.	O
No	O
tremor	O
or	O
asterixis.	O
Delt	O
Bic	O
Tri	O
ECR	O
Fext	O
IP	O
Quad	O
Ham	O
TA	O
Gas	O
___	O
L	O
5	O
5	O
___	O
5	O
5	O
5	O
5	O
5	O
5	O
R	O
5	O
5	O
___	O
5	O
5	O
5	O
5	O
5	O
5	O
-	O
Sensation	O
-	O
Intact	O
to	O
light	O
touch	O
in	O
all	O
four	O
extremities	O
-	O
DTRs	O
-	O
Bic	O
Tri	O
___	O
Quad	O
Gastroc	O
L	O
2	O
2	O
2	O
2	O
1	O
R	O
2	O
2	O
2	O
2	O
1	O
Plantar	O
response	O
downgoing	O
bilaterally.	O
-	O
Cerebellar	O
-	O
No	O
dysmetria	O
with	O
finger	O
to	O
nose	O
testing	O
bilaterally.	O
-	O
Gait	O
-	O
deferred	O
Pertinent	O
Results:	O
___	O
07:45AM	O
BLOOD	O
WBC-5.2	O
RBC-3.48*	O
Hgb-9.6*	O
Hct-31.7*	O
MCV-91	O
MCH-27.6	O
MCHC-30.3*	O
RDW-13.9	O
RDWSD-45.7	O
Plt	O
___	O
___	O
07:45AM	O
BLOOD	O
___	O
PTT-38.8*	O
___	O
___	O
04:45AM	O
BLOOD	O
___	O
PTT-38.6*	O
___	O
___	O
11:40AM	O
BLOOD	O
___	O
PTT-41.7*	O
___	O
___	O
07:45AM	O
BLOOD	O
Glucose-82	O
UreaN-32*	O
Creat-1.9*	O
Na-145	O
K-3.7	O
Cl-106	O
___	O
11:40AM	O
BLOOD	O
cTropnT-<0.01	O
proBNP-1629*	O
___	O
04:45AM	O
BLOOD	O
%HbA1c-5.2	O
eAG-103	O
___	O
04:45AM	O
BLOOD	O
Triglyc-125	O
HDL-41	O
CHOL/HD-3.1	O
LDLcalc-60	O
___	O
11:40AM	O
BLOOD	O
ASA-NEG	O
Ethanol-NEG	O
Acetmnp-NEG	O
Bnzodzp-NEG	O
Barbitr-NEG	O
Tricycl-NEG	O
NCHCT	B-Intracranial_haemorrhage
-	O
No	O
acute	O
infarct	O
or	O
hemorrhage,	B-Intracranial_haemorrhage
unchanged	O
left	O
frontal	O
lobe	O
encephalomalacia.	O
Carotid	O
U/S	O
-	O
(prelim	O
read)	O
no	O
evident	O
stenosis	O
Brain	O
MRI/MRA	O
No	O
evidence	O
of	O
acute	O
infarct	O
mass	O
effect	O
midline	O
shift	O
or	O
hydrocephalus.	O
Moderate	O
brain	O
atrophy	O
and	O
changes	O
of	O
small	O
vessel	O
disease	O
seen.	O
Chronic	O
left	O
parietal	O
infarct	O
is	O
identified.	O
No	O
evidence	O
of	O
acute	O
or	O
chronic	O
blood	O
products.	O
MRA	O
of	O
the	O
neck	O
demonstrates	O
flow	O
in	O
both	O
carotid	O
no	O
vertebral	O
arteries	O
without	O
stenosis	O
or	O
occlusion.	O
MRA	O
of	O
the	O
head	O
demonstrates	O
diminished	O
flow	O
in	O
the	O
basilar	O
artery.	O
This	O
is	O
similar	O
to	O
the	O
MRA	O
of	O
___.	O
This	O
may	O
be	O
secondary	O
to	O
slow	O
flow	O
or	O
chronic	O
occlusion	O
of	O
the	O
basilar	O
artery.	O
Flow	O
signal	O
is	O
identified	O
in	O
both	O
posterior	O
cerebral	O
arteries.	O
The	O
anterior	O
circulation	O
is	O
unremarkable.	O
Brief	O
Hospital	O
Course:	O
Mrs.	O
___	O
came	O
in	O
with	O
a	O
brief	O
spell	O
of	O
right	O
facial	O
weakness	O
in	O
the	O
setting	O
of	O
probable	O
UTI	B-Urinary_tract_infection
and	O
mild	O
CHF.	O
NCHCT	O
and	O
MRI	O
were	O
negative	O
for	O
acute	O
ischemia,	O
and	O
MRA/Carotid	O
US	O
showed	O
no	O
carotid	O
disease.	O
Her	O
exam	O
here	O
was	O
normal	O
on	O
arrival	O
and	O
continued	O
to	O
show	O
no	O
neurological	O
deficit.	O
___	O
felt	O
she	O
was	O
safe	O
to	O
discharge	O
with	O
home	O
___	O
with	O
___	O
for	O
INR	O
checks	O
while	O
on	O
warfarin	O
and	O
ASA.	O
Our	O
suspicion	O
is	O
that	O
she	O
had	O
brief	O
recrudescence	O
of	O
old	O
stroke	O
symptoms	O
in	O
the	O
setting	O
of	O
metabolic	O
problems.	O
She	O
was	O
therapeutic	O
on	O
warfarin/ASA	O
(INR	O
3.0	O
on	O
arrival,	O
2.1	O
at	O
discharge)	O
and	O
we	O
plan	O
to	O
continue	O
this.	O
She	O
will	O
have	O
Stroke	O
Clinic	O
follow	O
up.	O
TRANSITIONAL	O
ISSUES	O
-	O
INR	O
management.	O
In-house	O
the	O
patient	O
got	O
4mg	O
warfarin	O
daily,	O
due	O
to	O
uncertainty	O
of	O
dose	O
4mg	O
vs	O
5mg	O
daily.	O
Her	O
INR	O
remained	O
therapeutic	O
but	O
slowly	O
drifting	O
downward	O
and	O
needs	O
close	O
follow	O
up	O
___	O
(INR	O
___,	O
INR	O
___,	O
INR	O
___.	O
We	O
plan	O
to	O
discharge	O
her	O
on	O
the	O
home	O
coumadin	O
5mg	O
daily,	O
and	O
she	O
may	O
not	O
need	O
to	O
drop	O
the	O
dose	O
on	O
___.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H:PRN	O
pain	O
2.	O
Allopurinol	O
___	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
20	O
mg	O
PO	O
QPM	O
5.	O
Bisacodyl	O
5	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
6.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
7.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
DAILY	O
8.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
90	O
mg	O
PO	O
DAILY	O
9.	O
Latanoprost	O
0.005%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
QHS	O
10.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QAM	O
11.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
12.	O
Omeprazole	O
40	O
mg	O
PO	O
BID	O
13.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
14.	O
Spironolactone	O
25	O
mg	O
PO	O
DAILY	O
15.	O
Warfarin	O
5	O
mg	O
PO	O
6X/WEEK	O
(___)	O
16.	O
Warfarin	O
4	O
mg	O
PO	O
1X/WEEK	O
(MO)	O
17.	O
ammonium	O
lactate	O
12	O
%	O
topical	O
DAILY	O
18.	O
calcium	O
carbonate-vit	O
D3-min	O
600	O
mg	O
(1,500	O
mg)-400	O
unit	O
oral	O
BID	O
19.	O
Carbamide	O
Peroxide	O
6.5%	O
___	O
DROP	O
AD	O
BID	O
20.	O
Ketoconazole	O
2%	O
1	O
Appl	O
TP	O
BID	O
21.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
22.	O
Nystatin	O
Cream	O
1	O
Appl	O
TP	O
BID	O
23.	O
Torsemide	O
30	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H:PRN	O
pain	O
2.	O
Allopurinol	O
___	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
20	O
mg	O
PO	O
QPM	O
5.	O
Bisacodyl	O
5	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
6.	O
Carbamide	O
Peroxide	O
6.5%	O
___	O
DROP	O
AD	O
BID	O
7.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
8.	O
Latanoprost	O
0.005%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
QHS	O
9.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QAM	O
10.	O
Omeprazole	O
40	O
mg	O
PO	O
BID	O
11.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
12.	O
Spironolactone	O
25	O
mg	O
PO	O
DAILY	O
13.	O
Torsemide	O
30	O
mg	O
PO	O
DAILY	O
14.	O
Warfarin	O
5	O
mg	O
PO	O
6X/WEEK	O
(___)	O
15.	O
Warfarin	O
4	O
mg	O
PO	O
1X/WEEK	O
(MO)	O
16.	O
ammonium	O
lactate	O
12	O
%	O
topical	O
DAILY	O
17.	O
calcium	O
carbonate-vit	O
D3-min	O
600	O
mg	O
(1,500	O
mg)-400	O
unit	O
oral	O
BID	O
18.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
DAILY	O
19.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
90	O
mg	O
PO	O
DAILY	O
20.	O
Ketoconazole	O
2%	O
1	O
Appl	O
TP	O
BID	O
21.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
22.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
23.	O
Nystatin	O
Cream	O
1	O
Appl	O
TP	O
BID	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
facial	O
droop	O
recrudescence	O
of	O
prior	O
stroke	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
hospitalized	O
due	O
to	O
symptoms	O
of	O
shortness	O
of	O
breath	O
and	O
right	O
sided	O
weakness	O
that	O
resolved	O
by	O
the	O
time	O
you	O
arrived	O
to	O
the	O
hospital.	O
You	O
were	O
briefly	O
admitted	O
to	O
the	O
Neurology	O
Stroke	O
team	O
for	O
MRI	O
of	O
the	O
brain	O
to	O
look	O
for	O
stroke.	O
Fortunately	O
we	O
found	O
no	O
evidence	O
of	O
stroke.	O
On	O
labwork	O
we	O
found	O
that	O
you	O
likely	O
have	O
mild	O
worsening	O
of	O
your	O
long-standing	O
heart	O
failure	O
as	O
well	O
as	O
a	O
mild	O
urine	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
which	O
we	O
treated	O
with	O
antibiotics.	O
Sometimes	O
when	O
you	O
have	O
medical	O
problems,	O
symptoms	O
from	O
an	O
old	O
stroke	O
can	O
worsen	O
briefly.	O
We	O
think	O
this	O
was	O
the	O
case	O
with	O
your	O
facial	O
weakness.	O
We	O
found	O
no	O
evidence	O
to	O
suggest	O
that	O
your	O
symptoms	O
were	O
caused	O
by	O
a	O
stroke	O
or	O
TIA	O
and	O
we	O
were	O
reassured	O
by	O
your	O
normal	O
exam	O
in	O
the	O
hospital.	O
We	O
decided	O
to	O
continue	O
your	O
home	O
doses	O
of	O
aspirin	O
and	O
warfarin	O
for	O
future	O
stroke	O
prevention.	O
You	O
completed	O
a	O
3-day	O
course	O
of	O
antibiotics	O
for	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
and	O
need	O
no	O
further	O
treatment	O
at	O
this	O
time.	O
Please	O
take	O
your	O
other	O
medications	O
as	O
prescribed	O
and	O
follow-up	O
with	O
Neurology	O
and	O
your	O
primary	O
care	O
physician	O
as	O
listed	O
below.	O
If	O
you	O
experience	O
any	O
of	O
the	O
symptoms	O
below,	O
please	O
seek	O
emergency	O
medical	O
attention	O
by	O
calling	O
Emergency	O
Medical	O
Services	O
(dialing	O
911).	O
In	O
particular,	O
since	O
stroke	O
can	O
recur,	O
please	O
pay	O
attention	O
to	O
the	O
sudden	O
onset	O
and	O
persistence	O
of	O
these	O
symptoms:	O
-	O
sudden	O
partial	O
or	O
complete	O
loss	B-Visual_impairment
of	B-Visual_impairment
vision	B-Visual_impairment
-	O
sudden	O
loss	O
of	O
the	O
ability	O
to	O
speak	O
words	O
from	O
your	O
mouth	O
-	O
sudden	O
loss	O
of	O
the	O
ability	O
to	O
understand	O
others	O
speaking	O
to	O
you	O
-	O
sudden	O
weakness	O
of	O
one	O
side	O
of	O
the	O
body	O
-	O
sudden	O
drooping	O
of	O
one	O
side	O
of	O
the	O
face	O
-	O
sudden	O
loss	O
of	O
sensation	O
of	O
one	O
side	O
of	O
the	O
body	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
Followup	O
Instructions:	O
___	O

